Our research expertise spans cancer genomics, DNA damage, RNA biology, and drug development. We are also expanding our focus on drug delivery, particularly through nanotechnology-based methods for delivering small RNA mimics and inhibitors.
News
- NPJ – Precision Oncology: Benchmarking mouse contamination removing protocols in patient-derived xenografts genomic profiling (Zheng, Wang, Kurmasheva, Houghton, Lai, & Chen Labs)
- Clinical Cancer Research: Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric NF2-, SMARCB1-, and LZTR1-Related Schwannomatosis (Tomlinson)
- IScience: Dissection of tumoral niches using spatial transcriptomics and deep learning (Chen)
- Structure: Structural insights into the assembly and regulation of 2′-O RNA methylation by SARS-CoV-2 nsp16/nsp10 (Gupta Lab)
- Neuro-Oncology: Dual Inhibition of MAPK and TORC1 Signaling Retards Development of Radiation Resistance in Pediatric BRAF V600E Glioma Models (Chen, Houghton, et al labs)
Events
Greehey CCRI Seminar Series: Gang Huang (UTHSA, Department of Cell Systems and Anatomy)
Presentation title: Anemia: Causes, Mechanisms, and Treatments
Greehey CCRI Seminar Series: Andrew J Brenner, MD, PhD (UTHSA – Dept Cell Systems and Anatomy)
Presentation title: TBD
4th Annual Gear Up Against Kids Cancer Bike Ride
With cycling becoming an increasingly popular activity in San Antonio and south Texas, the Gear Up Against Kids Cancer was launched on April 2, 2022, to address a critical need for increased support for pediatric cancer research.